LigaChem Biosciences Statistics

Total Valuation

LigaChem Biosciences has a market cap or net worth of KRW 4.37 trillion. The enterprise value is 3.83 trillion.

Market Cap	4.37T
Enterprise Value	3.83T

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

LigaChem Biosciences has 36.43 million shares outstanding. The number of shares has decreased by -18.77% in one year.

Current Share Class	n/a
Shares Outstanding	36.43M
Shares Change (YoY)	-18.77%
Shares Change (QoQ)	-26.35%
Owned by Insiders (%)	4.22%
Owned by Institutions (%)	13.71%
Float	25.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	49.53
PB Ratio	6.99
P/TBV Ratio	n/a
P/FCF Ratio	78.80
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-112.73
EV / Sales	50.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	68.99

Financial Position

The company has a current ratio of 5.43, with a Debt / Equity ratio of 0.02.

Current Ratio	5.43
Quick Ratio	5.37
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	0.23
Interest Coverage	-94.28

Financial Efficiency

Return on equity (ROE) is -8.38% and return on invested capital (ROIC) is -7.99%.

Return on Equity (ROE)	-8.38%
Return on Assets (ROA)	-6.97%
Return on Capital (ROIC)	-7.99%
Revenue Per Employee	485.45M
Profits Per Employee	-216.23M
Employee Count	157
Asset Turnover	0.16
Inventory Turnover	80.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +173.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+173.81%
50-Day Moving Average	112,634.00
200-Day Moving Average	80,672.25
Relative Strength Index (RSI)	47.62
Average Volume (20 Days)	867,864

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LigaChem Biosciences had revenue of KRW 76.22 billion and -33.95 billion in losses. Loss per share was -1,079.09.

Revenue	76.22B
Gross Profit	60.20B
Operating Income	-53.36B
Pretax Income	-35.54B
Net Income	-33.95B
EBITDA	-48.51B
EBIT	-53.36B
Loss Per Share	-1,079.09

Full Income Statement

Balance Sheet

The company has 557.28 billion in cash and 12.82 billion in debt, giving a net cash position of 544.47 billion or 14,946.62 per share.

Cash & Cash Equivalents	557.28B
Total Debt	12.82B
Net Cash	544.47B
Net Cash Per Share	14,946.62
Equity (Book Value)	624.98B
Book Value Per Share	17,157.00
Working Capital	475.54B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 56.83 billion and capital expenditures -1.36 billion, giving a free cash flow of 55.47 billion.

Operating Cash Flow	56.83B
Capital Expenditures	-1.36B
Free Cash Flow	55.47B
FCF Per Share	1,522.78

Full Cash Flow Statement

Margins

Gross margin is 78.98%, with operating and profit margins of -70.01% and -44.54%.

Gross Margin	78.98%
Operating Margin	-70.01%
Pretax Margin	-46.64%
Profit Margin	-44.54%
EBITDA Margin	-63.65%
EBIT Margin	-70.01%
FCF Margin	72.78%

Dividends & Yields

LigaChem Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	18.77%
Shareholder Yield	18.77%
Earnings Yield	-0.90%
FCF Yield	1.27%

Stock Splits

The last stock split was on June 16, 2020. It was a forward split with a ratio of 2.

Last Split Date	Jun 16, 2020
Split Type	Forward
Split Ratio	2

Scores

LigaChem Biosciences has an Altman Z-Score of 8.63.

Altman Z-Score	8.63
Piotroski F-Score	n/a